Results 111 to 120 of about 640 (208)

In Silico Comparison of Bioactive Compounds Characterized from Azadirachta indica with an FDA-Approved Drug against Schistosomal Agents: New Insight into Schistosomiasis Treatment. [PDF]

open access: yesMolecules
Oyinloye BE   +12 more
europepmc   +1 more source

Plumbagin: A Promising In Vivo Antiparasitic Candidate against Schistosoma mansoni and In Silico Pharmacokinetic Properties (ADMET). [PDF]

open access: yesBiomedicines, 2023
Silva LMN   +15 more
europepmc   +1 more source

Schistosomicidal effects of histone acetyltransferase inhibitors against Schistosoma japonicum juveniles and adult worms in vitro. [PDF]

open access: yesPLoS Negl Trop Dis
Xu J   +10 more
europepmc   +1 more source

Development of the PraziCalc mobile device-app to calculate praziquantel dosage in the treatment of schistosomiasis. [PDF]

open access: yesRev Inst Med Trop Sao Paulo, 2018
Viana AG   +6 more
europepmc   +1 more source

Prevalence of urogenital and intestinal schistosomiasis among school children in South-west Nigeria. [PDF]

open access: yesPLoS Negl Trop Dis, 2021
Ojo JA   +8 more
europepmc   +1 more source

Development of non-sedating benzodiazepines with in vivo antischistosomal activity. [PDF]

open access: yesAntimicrob Agents Chemother
Mian MY   +13 more
europepmc   +1 more source

Nature-Inspired Gallinamides Are Potent Antischistosomal Agents: Inhibition of the Cathepsin B1 Protease Target and Binding Mode Analysis. [PDF]

open access: yesACS Infect Dis
Spiwoková P   +16 more
europepmc   +1 more source

A multi-dimensional, time-lapse, high content screening platform applied to schistosomiasis drug discovery. [PDF]

open access: yesCommun Biol, 2020
Chen S   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy